These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5463297)

  • 1. Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.
    Dvilansky A; Britten AF; Loewy AG
    Br J Haematol; 1970 Apr; 18(4):399-410. PubMed ID: 5463297
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor XIII assay by an isotope method. II. Heparin inhibition of factor XIII activation.
    Dvilansky A; Britten AF; Loewy AG
    Thromb Diath Haemorrh; 1970 Oct; 24(1):256-64. PubMed ID: 5483966
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor XIII and transamidase activities in human blood platelets.
    Tsukada T
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):984-94. PubMed ID: 610335
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the fibrin stabilizing factor in human platelets: its content in normal thrombocytes and in platelets with functional defects.
    Wenzel E; Oppolzer R
    Acta Univ Carol Med Monogr; 1972; 53():173-8. PubMed ID: 4133928
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII (fibrin-stabilizing factor) and platelets. I. Study of the association of factor XIII with blood platelets.
    Rolović Z
    Acta Med Iugosl; 1968; 22(1):113-23. PubMed ID: 5735663
    [No Abstract]   [Full Text] [Related]  

  • 7. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma factor XIII and platelet factor XIII in hyperlipaemia.
    Cucuianu MP; Miloszewski K; Porutiu D; Losowsky MS
    Thromb Haemost; 1976 Dec; 36(3):542-50. PubMed ID: 1037152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor XIII concentration in sickle-cell disease.
    Ittyerah R; Alkjaersig N; Fletcher A; Chaplin H
    J Lab Clin Med; 1976 Oct; 88(4):546-54. PubMed ID: 965808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
    Henriksson P; Stenberg P; Nilsson IM; Rasovic N; Kezic J; Stenbjerg S
    Br J Haematol; 1980 Jan; 44(1):141-7. PubMed ID: 6155132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A solid-phase radioassay for factor-XIII activity (fibrin stabilizing factor) in human plasma.
    Schmer G
    Br J Haematol; 1973 Jun; 24(6):735-42. PubMed ID: 4716057
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subunit B of factor XIII is present in bovine platelets.
    Takagi J; Kasahara K; Sekiya F; Inada Y; Saito Y
    Thromb Res; 1988 Jun; 50(6):767-74. PubMed ID: 3046042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern use of blood.
    Smiley RK
    Can J Surg; 1972 Sep; 15(5):321-5. PubMed ID: 5056996
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of plasma transamidase activity in congenital deficiency of fibrin stabilizing factor (Factor 13).
    Miloszewski K; Walls WD; Losowsky MS
    Br J Haematol; 1969 Aug; 17(2):159-62. PubMed ID: 5804403
    [No Abstract]   [Full Text] [Related]  

  • 17. [The dynamics of the activity of various clotting and fibrinolytic factors in preserved blood in relation to duration of blood storage].
    Kal'chenko II; Lys PV; Riabyĭ PA
    Vestn Khir Im I I Grek; 1971 Oct; 107(10):122-6. PubMed ID: 5142224
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of oral contraceptives on fibrin-clot stabilization.
    Shanberge JN; Tanaka K; Gruhl MC; Ikemori R; Inoshita K
    Ann N Y Acad Sci; 1972 Dec; 202():220-9. PubMed ID: 4508925
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymatic method for the quantitative determination of factor. XIII. Application to a familial deficiency.
    Janssen CL; Masure R
    Pathol Eur; 1970; 5(3):315-30. PubMed ID: 5477027
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
    Kłoczko J; Wereszczyńska U; Wojtukiewicz M; Gybryelewicz A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):539-44. PubMed ID: 2431976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.